Postpartum Psychiatric Disorders

Perinatal Depression: Can We Predict Who is At Risk for Suicide?

It is estimated that suicide accounts for about 10% of all maternal deaths. While we have a fair amount of information to help us predict which women are at risk for depression during pregnancy and [...]

By |2019-06-07T08:46:33-04:00June 29th, 2017|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Perinatal Depression: Can We Predict Who is At Risk for Suicide?

Does Universal Screening for Depression in Perinatal Populations Lead to Better Outcomes?

Over the last decade, there has been increased interest around the country in establishing consistent screening for perinatal depression across a range of clinical settings. Approximately 40 states have instituted guidelines and recommendations regarding screening [...]

By |2025-12-11T09:56:53-04:00June 27th, 2017|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Does Universal Screening for Depression in Perinatal Populations Lead to Better Outcomes?

New Study at the CWMH: Brexanolone (SAGE-547) for Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is a new type of antidepressant: a formulation of allopregnanolone, which is [...]

By |2017-07-03T13:52:30-04:00June 22nd, 2017|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on New Study at the CWMH: Brexanolone (SAGE-547) for Postpartum Depression

In Brief: Problem-Solving Education Intervention Reduces Risk of Postpartum Depression

While many women are at risk for postpartum depression, we continue to struggle in providing adequate support and care to women in this setting, especially socioeconomically disadvantaged women.   In a randomized clinical trial including [...]

By |2017-07-05T22:29:29-04:00June 20th, 2017|Postpartum Psychiatric Disorders|Comments Off on In Brief: Problem-Solving Education Intervention Reduces Risk of Postpartum Depression

Lamotrigine Reduces Risk for Postpartum Relapse in Women with Bipolar Disorder

Numerous studies have demonstrated that women with histories of bipolar disorder are at high risk for postpartum illness.  Because of this increased risk for relapse during the postpartum period, we typically recommend that women with [...]

By |2025-06-26T09:07:00-04:00May 30th, 2017|Postpartum Psychiatric Disorders|Comments Off on Lamotrigine Reduces Risk for Postpartum Relapse in Women with Bipolar Disorder

Pilot Study of Telephone-Delivered Interpersonal Therapy for Women with Postpartum Depression

It is clear that screening for perinatal depression substantially improves detection; however, screening alone does not appear to improve rates of treatment or outcomes.  What we find is that many, if not most, women with [...]

By |2017-05-24T09:40:10-04:00May 24th, 2017|Postpartum Psychiatric Disorders|Comments Off on Pilot Study of Telephone-Delivered Interpersonal Therapy for Women with Postpartum Depression

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]

By |2017-05-10T09:40:41-04:00May 10th, 2017|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression
Go to Top